US Stock MarketDetailed Quotes

KTTA Pasithea Therapeutics

Watchlist
  • 1.4500
  • -0.0100-0.68%
Close Feb 14 16:00 ET
  • 1.3614
  • -0.0886-6.11%
Post 19:50 ET
1.84MMarket Cap-0.10P/E (TTM)

About Pasithea Therapeutics Company

Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.

Company Profile

SymbolKTTA
Company NamePasithea Therapeutics
Listing DateSep 15, 2021
Issue Price4.99
Founded2020
CEODr. Tiago Reis Marques
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address1111 Lincoln Road,Suite 500
CityMiami Beach
ProvinceFlorida
CountryUnited States of America
Zip Code33139
Phone1-702-514-4174

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Tiago Reis Marques
  • Chief Executive Officer and Director
  • --
  • Daniel Schneiderman
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Graeme Martin Currie, PhD
  • Chief Development Officer
  • --
  • Dr. Lawrence J. Steinman, M.D.
  • Executive Chairman of the Board
  • --
  • Alfred J Novak
  • Independent Director
  • --
  • Dr. Emer Leahy
  • Independent Director
  • --
  • Simon Dumesnil
  • Independent Director
  • --

Trending Stocks

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.